Search Results - "Nassour, Lauren"

A Century of Fractionated Radiotherapy: How Mathematical Oncology Can Break the Rules by Ghaderi, Nima, Jung, Joseph, Brüningk, Sarah C, Subramanian, Ajay, Nassour, Lauren, Peacock, Jeffrey

“…Radiotherapy is involved in 50% of all cancer treatments and 40% of cancer cures. Most of these treatments are delivered in fractions of equal doses of…”
Get full text

STEM-18. A HIGH THROUGHPUT NEUROSPHERE BASED COLONY FORMATION ASSAY TO VALIDATE DRUG AND RADIATION EFFECTIVENESS IN PATIENT DERIVED XENOLINES by Kumar, Manoj, Anderson, Joshua, Alrefai, Hasan, Nassour, Lauren, Schanel, Taylor, Hicks, Patricia, Willey, Christopher

“…Abstract Glioblastoma (GBM) is a primary malignant brain tumor developed from normal astrocytes. GBM patients’ median survival is less than 2 years despite…”
Get full text

MODL-30. UTILIZING SERUM-FREE CO-CULTURE MODELS FOR IN-VITRO MODELING OF TUMOR-ASSOCIATED MACROPHAGES IN GLIOBLASTOMA by Alrefai, Hasan, Kumar, Manoj, Nassour, Lauren, Schanel, Taylor, Beierle, Andee, Anderson, Joshua, Hicks, Patricia, Willey, Christopher

“…Abstract BACKGROUND The GBM tumor microenvironment consists of various cancerous and non-cancerous cells that influence GBM growth, invasion, angiogenesis, and…”
Get full text

Exposure to Moderate Glycosuria Induces Virulence of Group B Streptococcus by John, Preeti P, Baker, Brady C, Paudel, Santosh, Nassour, Lauren, Cagle, Hayden, Kulkarni, Ritwij

“…Abstract To explore whether glycosuria induces virulence of uropathogens, in turn facilitating urinary tract infection (UTI), we exposed group B Streptococcus…”
Get full text

miRNA Signatures for a Human Proteotoxic Cardiac Disease by Nassour, Lauren, Sunny, Sini, Jyothidasan, Arun, Kumar S Narasimhan, Kishore, Dalley, Brian, Benjamin, Ivor, Namakkal-Soorappan, Rajasekaran

Get full text

TMOD-21. A NOVEL IN-VITRO METHOD TO MODEL MACROPHAGES IN GLIOBLASTOMA by Alrefai, Hasan, Beierle, Andee, Nassour, Lauren, Eustace, Nicholas, Patel, Zeel, Anderson, Joshua, Hicks, Patricia, King, Peter, Willey, Christopher

“…Abstract BACKGROUND The GBM tumor microenvironment (TME) is comprised of a plethora of cancerous and non-cancerous cells that contribute to GBM growth,…”
Get full text

Abstract 4668: In-vitro modeling of tumor-associated macrophages in glioblastoma by Alrefai, Hasan, Beierle, Andee M., Schanel, Taylor L., Nassour, Lauren C., Anderson, Joshua C., Hicks, Patricia H., Willey, Christopher D.

“…Abstract BACKGROUND: The Glioblastoma (GBM) tumor microenvironment (TME) is comprised of a plethora of cancerous and non-cancerous cells that contribute to GBM…”
Get full text

Abstract 3568: Developing pediatric glioblastoma microtumors with a three-dimensional bioprinter by Beierle, Andee M., Schanel, Taylor L., Alrefai, Hasan, Anderson, Joshua C., Hicks, Patricia H., Nassour, Lauren C., Willey, Christopher D.

“…Abstract Background:Glioblastoma multiforme is one of the most devastating forms of brain cancer seen in children. Children diagnosed with high-grade gliomas…”
Get full text

Abstract 1102: Establishing the cytotoxic benefit of Tumor Treating Fields on radiation sensitive and acquired radiation resistant glioblastoma patient derived xenograft pairs by Schanel, Taylor L., Jones, Amber B., Beierle, Andee M., Alrefai, Hasan, Nassour, Lauren C., Hicks, Patricia H., Anderson, Joshua C., Hjelmeland, Anita B., Willey, Christopher D.

“…Abstract Background: Glioblastoma (GBM) is the most common malignant primary brain tumor with very poor prognosis. The current standard of care for GBM…”
Get full text

TMOD-25. UTILIZING PRIMARY MACROPHAGES AS AN IMPROVED SERUM-FREE IN VITRO MODEL OF TUMOR-ASSOCIATED MACROPHAGES IN GLIOBLASTOMA by Alrefai, Hasan, Elkholy, Amr, Lin, Benjamin, Kumar, Manoj, Schanel, Taylor, Nassour-Caswell, Lauren, Anderson, Joshua, Hicks, Patricia, Ahn, Erin, Miller, C Ryan, Willey, Christopher

“…Abstract BACKGROUND Tumor-associated macrophages (TAMs) account for up to 40% of tumor mass in glioblastoma and over 70% of the immune cells contained therein…”
Get full text

Abstract 1273: Glioblastoma brain tumor-initiating cells are protected from hypoxia when co-cultured with normal human astrocytes revealing a potential role for mitochondrial transfer via tunneling nanotubes by Nassour-Caswell, Lauren C., Eustace, Nicholas J., Stackhouse, Christian T., Alrefai, Hasan, Hicks, Patricia H., Schanel, Taylor L., Anderson, Joshua C., Beierle, Andee M., Willey, Christopher D.

“…Abstract Background: Glioblastoma (GBM) has a median survival of <2 years and generally recurs within 6 months of treatment due to the development of chemo-…”
Get full text

Abstract 3360: Myristoylated alanine-rich C-kinase substrate (MARCKS) as a target for pathological tunneling nanotubes in glioblastoma by Nassour-Caswell, Lauren C., Eustace, Nicholas J., Rich-New, Shane T., Schanel, Taylor L., Alrefai, Hasan, Beierle, Andee M., Kumar, Manoj, Hicks, Patricia H., Anderson, Johsua C., Willey, Christopher D.

“…Abstract Background: Glioblastoma (GBM) is a lethal brain malignancy with a median survival of <2 years due to relapse in 100% of cases. Tunneling nanotubes…”
Get full text